Postoperative Analgesic Efficacy of Continuous Wound Infusion After Laparoscopy

• Status: Unknown status
• Trial end date: 2020-04-03
• Target enrollment: 0
• Participant gender: Female

Summary

Studies evaluating the effectiveness of continuous wound infusion (CWI) to manage postoperative pain following laparoscopy are markedly lacking. Especially, there was no study comparing CWI and placebo in treating gynecologic laparoscopy. Therefore, the investigators conducted this randomized, double-blind, placebo-controlled trial to investigate whether CWI of local anesthetics was an effective strategy for enhanced recovery after surgery (ERAS), compared with placebo in patients undergoing benign gynecologic laparoscopy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kangbuk Samsung Hospital
• Treatments: Analgesics; Ropivacaine

Criteria

Inclusion Criteria:

• age between 18 and 80 years,

• American Society of Anesthesiologists physical status (ASAPS) classification I-II

• the absence of pregnancy at the time of surgery

Exclusion Criteria:

• allergy to amide local anesthetics including ropivacaine

• laparoscopic surgery needing ≥ 3 separate skin incisions

• history of ventral or incisional hernia

• pre-existing coagulopathy, neurologic or cognitive dysfunction

• systemic or regional (especially, umbilicus) infection

• previously taking opioids for acute or chronic pain

• inability to accurately express their pain.